Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhanced MAPK signaling is essential for CSF3R-induced leukemia.
Rohrabaugh S, Kesarwani M, Kincaid Z, Huber E, Leddonne J, Siddiqui Z, Khalifa Y, Komurov K, Grimes HL, Azam M. Rohrabaugh S, et al. Among authors: kincaid z. Leukemia. 2017 Aug;31(8):1770-1778. doi: 10.1038/leu.2016.376. Epub 2016 Dec 27. Leukemia. 2017. PMID: 28031554 Free PMC article.
MEK/ERK addiction in CNL/aCML.
Kesarwani M, Kincaid Z, Azam M. Kesarwani M, et al. Among authors: kincaid z. Oncotarget. 2017 Nov 3;8(59):99215-99216. doi: 10.18632/oncotarget.22283. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29245892 Free PMC article. No abstract available.
Momelotinib is a highly potent inhibitor of FLT3-mutant AML.
Azhar M, Kincaid Z, Kesarwani M, Ahmed A, Wunderlich M, Latif T, Starczynowski D, Azam M. Azhar M, et al. Among authors: kincaid z. Blood Adv. 2022 Feb 22;6(4):1186-1192. doi: 10.1182/bloodadvances.2021004611. Blood Adv. 2022. PMID: 34768286 Free PMC article.
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML.
Azhar M, Kincaid Z, Kesarwani M, Menke J, Schwieterman J, Ansari S, Reaves A, Ahmed A, Shehzad R, Khan A, Syed N, Amir N, Wunderlich M, Latif T, Seibel W, Azam M. Azhar M, et al. Among authors: kincaid z. Blood Adv. 2023 Apr 25;7(8):1460-1476. doi: 10.1182/bloodadvances.2022007486. Blood Adv. 2023. PMID: 36044389 Free PMC article.
MAPK-negative feedback regulation confers dependence to JAK2V617F signaling.
Kesarwani M, Kincaid Z, Azhar M, Menke J, Schwieterman J, Ansari S, Reaves A, Deininger ME, Levine R, Grimes HL, Azam M. Kesarwani M, et al. Among authors: kincaid z. Leukemia. 2023 Aug;37(8):1686-1697. doi: 10.1038/s41375-023-01959-0. Epub 2023 Jul 10. Leukemia. 2023. PMID: 37430058 Free PMC article.
12 results